Short communication| Volume 345, ISSUE 1-2, P248-251, October 15, 2014

Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study


      • Evaluation of differences in natural killer receptor expression in MS patients
      • Newly diagnosedpatients havea higher NCR1 expression level than other groups.
      • Pharmacologically treated MS patients show a modulated NK cell expression.


      Natural killer (NK) cells are implicated in many autoimmune diseases but their role in multiple sclerosis (MS) remains still unknown. This study was aimed to evaluate the expression levels of a NK cell receptor (NCR1) in patients with diagnosis of MS. Particularly, the study took into account patients undergoing pharmacological therapy with interferon-beta or natalizumab and patients never treated since first-time diagnosed for MS.
      Expression levels of NCR1 receptor were evaluated in protein extracts of peripheral blood mononuclear cells performing western blot analysis.
      Our results show that MS patients display higher NCR1 expression levels than healthy controls. Moreover, patients with a first diagnosis of MS display the highest level of NCR1 when compared with patients pharmacologically treated with interferon-beta or natalizumab.
      Therefore, pharmacologically treated MS patients show a modulated NK cell expression.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kingwell E.
        • Marriott J.J.
        • Jette N.
        • Pringsheim T.
        • Makhani N.
        • Morrow S.A.
        • et al.
        Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
        BMC Neurol. 2013; 13: 128
        • Trojano M.
        • Lucchese G.
        • Graziano G.
        • Taylor B.V.
        • Simpson Jr., S.
        • Lepore V.
        • et al.
        Geographical variations in sex ratio trends over time in multiple sclerosis.
        PLoS One. 2012; 7: e48078
        • Constantinescu C.S.
        • Farooqi N.
        • O'Brien K.
        • Gran B.
        Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
        Br J Pharmacol. 2011; 164: 1079-1106
        • Chanvillard C.
        • Jacolik R.F.
        • Infante-Duarte C.
        • Nayak R.C.
        The role of natural killer cells in multiple sclerosis and their therapeutic implications.
        Front Immunol. 2013; 4: 63
        • Nuyts A.H.
        • Lee W.P.
        • Bashir-Dar R.
        • Berneman Z.N.
        • Cools N.
        Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?.
        Mult Scler. 2013; 19: 995-1002
        • Kaur G.
        • Trowsdale J.
        • Fugger L.
        Natural killer cells and their receptors in multiple sclerosis.
        Brain. 2013; 136: 2657-2676
        • Fogel L.A.
        • Yokoyama W.M.
        • French A.R.
        Natural killer cells in human autoimmune disorders.
        Arthritis Res Ther. 2013; 15: 216
        • Durrenberger P.F.
        • Ettorre A.
        • Kamel F.
        • Webb L.V.
        • Sim M.
        • Nicholas R.S.
        • et al.
        Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).
        J Neuroinflammation. 2012; 9: 1
        • Mandelboim O.
        • Lieberman N.
        • Lev M.
        • Paul L.
        • Arnon T.I.
        • Bushkin Y.
        • et al.
        Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.
        Nature. 2001; 409: 1055-1060